|
ZNF239 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.794400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.274400E-01 |
| Normal-vs-Stage2 |
1.590390E-01 |
| Normal-vs-Stage3 |
1.976420E-01 |
| Normal-vs-Stage4 |
6.553600E-04 |
| Stage1-vs-Stage2 |
7.286200E-01 |
| Stage1-vs-Stage3 |
6.174200E-02 |
| Stage1-vs-Stage4 |
1.90414999999833E-05 |
| Stage2-vs-Stage3 |
5.170400E-02 |
| Stage2-vs-Stage4 |
2.622400E-03 |
| Stage3-vs-Stage4 |
3.591600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.139400E-01 |
| Normal-vs-AfricanAmerican |
5.238400E-01 |
| Normal-vs-Asian |
1.915570E-01 |
| Caucasian-vs-AfricanAmerican |
7.540200E-01 |
| Caucasian-vs-Asian |
1.756840E-01 |
| AfricanAmerican-vs-Asian |
1.689430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.185200E-01 |
| Normal-vs-Female |
9.010500E-02 |
| Male-vs-Female |
1.744900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.100000E-01 |
| Normal-vs-Extreme_Weight |
1.719970E-01 |
| Normal-vs-Obese |
7.307800E-01 |
| Normal-vs-Extreme_Obese |
1.076200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.756100E-02 |
| Normal_Weight-vs-Obese |
2.243600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.328200E-02 |
| Extreme_Weight-vs-Obese |
2.971600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.309800E-01 |
| Obese-vs-Extreme_Obese |
2.595600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.622580E-01 |
| Normal-vs-Age(41-60Yrs) |
6.618400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.198400E-01 |
| Normal-vs-Age(81-100Yrs) |
7.64619999999994E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.951160E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.570100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.516230E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.736100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.94979999999101E-07 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.810800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.938000E-02 |
| Normal-VS-Type2 PRCC |
6.284600E-01 |
| Normal-VS-KIRP CIMP |
3.584500E-02 |
| Normal-VS-Unclassified PRCC |
2.114000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.947800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.384260E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.997900E-03 |
| Type2 PRCC-VS-KIRP CIMP |
4.880900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.438970E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.869900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.987600E-02 |
| Normal-vs-N1 |
1.318240E-02 |
| Normal-vs-N2 |
5.586800E-01 |
| N0-vs-N1 |
1.699910E-03 |
| N0-vs-N2 |
3.833800E-01 |
| N1-vs-N2 |
6.377400E-01 |
|
|
